Domestic vitamin market continues to be sluggish, breeding demand by the market, livestock and poultry epidemic, etc., the performance continues to be poor. Upstream factories are more willing to support prices, the downstream hard demand is dominated by the small amount of serious than the price. The middle and upper reaches to relieve the pressure of capital and inventory, bargaining low price transactions, categories of transaction prices are broad and the center of gravity gradually down. Recent vitamin A, vitamin B1, folic acid and other products, the middle and upper reaches of the inventory pressure, bargaining shipments, need to focus on.

Vitamin A: recent market demand is poor, trade channels capital inventory pressure, low selling domestic bargaining transactions, individual regional prices are lower, the market price index weak running.

Vitamin E: the mainstream plant offers adhere to the high level, domestic and foreign inquiries increased attention, but the market demand is sluggish, bargaining transactions, local transactions are even lower, the market price index oscillating operation.

Folic acid: cost impact, the mainstream plant to raise the offer test, market transactions are poor, not rising back down, bargaining transactions are dominated, the market price index is weak.

Vitamin C: The international epidemic, as the mainstream anti-epidemic category, the domestic inquiry orders to purchase less than the previous period, the market willingness to ship to enhance the market price index slackened back.